LUNG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Pulmonx Corp (LUNG) is not a strong buy at the moment for a beginner investor with a long-term strategy. While hedge funds are showing significant interest, the company's financial performance is weak, with declining net income and EPS. Additionally, there are no strong technical or proprietary trading signals to support immediate action. The lack of recent news or significant positive catalysts further supports a 'hold' recommendation.
The MACD is positive and expanding, indicating a bullish momentum. However, the RSI is neutral at 72.086, and moving averages are converging, suggesting no clear trend. The stock is trading near its R1 resistance level of 1.634, with key support at 1.523.
Hedge funds are significantly increasing their positions, with a 1169.71% increase in buying over the last quarter. Gross margin has improved to 74.65%, up 1.29% YoY.
Net income and EPS have declined YoY, with net income dropping by -1.32% and EPS decreasing by -5.56%. There is no significant insider trading activity, no recent news, and no recent congress trading data. The stock has no strong proprietary trading signals or clear technical breakout.
In Q3 2025, revenue increased by 5.47% YoY to $21.5M, but net income dropped to -$13.96M (-1.32% YoY), and EPS decreased to -0.34 (-5.56% YoY). Gross margin improved slightly to 74.65% (+1.29% YoY).
No data available for recent analyst ratings or price target changes.
